Related Experiment Video
Updated: Feb 18, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Lipodystrophy among HIV-Infected Patients Attending Care and Treatment Clinics in Dar es Salaam
Marina Njelekela1, Rose Mpembeni2, Alfa Muhihi3
1Department of Physiology, Muhimbili University of Health and Allied Sciences, P.O. Box 65001, Dar es Salaam, Tanzania.
Insights
Lipodystrophy affects 20.4% of HIV patients in Tanzania, particularly males and those on long-term HAART. Early screening and management are crucial for addressing this condition and its impact on patient well-being.
Area of Science:
- Infectious Diseases
- Metabolic Disorders
- Public Health
Background:
- HIV infection and its treatment, highly active antiretroviral therapy (HAART), can lead to metabolic and morphological changes.
- Lipodystrophy, a condition characterized by abnormal fat distribution, is a known complication associated with HIV and HAART.
- Understanding the prevalence and risk factors of lipodystrophy in specific populations is crucial for effective patient management.
Purpose of the Study:
- To determine the prevalence and types of lipodystrophy among HIV-infected adults in Dar es Salaam, Tanzania.
- To identify sociodemographic and clinical risk factors associated with lipodystrophy in this population.
- To assess the impact of lipodystrophy on patients' body image and social interactions.
Main Methods:
- A cross-sectional study involving 466 HIV-infected patients attending a care and treatment center (CTC).
- Data collection through structured questionnaires covering sociodemographic and clinical information.
- Clinical diagnosis of lipodystrophy was performed by physicians.
Main Results:
- Lipodystrophy was diagnosed in 95 (20.4%) participants.
- Lipoatrophy was the most common form (49.5%), followed by mixed lipodystrophy (37.9%) and lipohypertrophy (12.6%).
- Male gender, older age, longer duration on HAART, and use of Stavudine-containing regimens were significant risk factors (p < 0.05).
- Male participants had 1.6 times the risk, while those on HAART had 13.3 times the risk of lipodystrophy.
- Lipodystrophy was linked to poor body image perception and reduced social interactions.
Conclusions:
- Lipodystrophy is a prevalent complication among HIV-infected patients in Tanzania, particularly affecting males and those on extended HAART.
- The findings underscore the need for regular screening and monitoring of lipodystrophy in HIV-infected individuals.
- Patient education and timely intervention are essential for managing lipodystrophy and mitigating its psychosocial effects.
Background:
HIV infection and long-term HAART use are associated with metabolic and morphological changes. We assessed prevalence, types, and risk factors associated with lipodystrophy among HIV-infected adults attending CTC in Dar es Salaam, Tanzania.
Methods:
Analysis included 466 HIV-infected patients. Study protocol involved administration of structured questionnaire to collect sociodemographic and clinical information. Diagnosis of lipodystrophy was based on physician clinical assessment.
Results:
Lipodystrophy was present in 95 (20.4%) of the study participants, with lipoatrophy being the most common (49.5%) followed by mixed lipodystrophy (37.9%), and lipohypertrophy was the least prevalent (12.6%). Male gender, older age, long duration on HAART, and use of Stavudine containing regimen were associated with lipodystrophy (all p < 0.05). The risk for lipodystrophy was 1.6 times (AOR = 1.66, 95% CI = 1.01-2.72) for male participants and 13.3 times (AOR = 13.3, 95% CI = 6.4-27.7) for those on HAART. Long duration on HAART and use of Stavudine containing regimen were also associated with increased risk for lipodystrophy. Lipodystrophy was associated with poor perception about own body image and decreased social interactions.
Conclusions:
Lipodystrophy is common among HIV-infected patients in Tanzania, especially among male patients and those on HAART. Regular screening, monitoring, and patient awareness are needed for early identification and appropriate management.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Immunodeficiency Diseases
There are three main causes of immunodeficiency...
Retrovirus Life Cycles
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...

